Get Permission Patil, Rane, and Khokar: To assess calretinin immunohistochemistry in Hirschsprung’s disease and allied disorders


Introduction

Hirschsprung’s disease (HD) is the congenital aganglionosis of the human colon due to disruption of migration, imbalanced proliferation and differentiation of neural crest cell. Hirschsprung’s disease affects an estimated 1:5000 live born. Approximately 90% of patients present in infancy with constipation, abdominal distension, vomiting, and delay of meconium passage. Aganglionosis always involves the distal rectum, but frequently extends in a proximal direction to a variable length of bowel: to sigmoid colon (short segment HD), to left, transverse, or right colon (long segment HD), or, in rare and severe forms, to the distal ileum (total colonic aganglionosis [TCA]), or skip segment Hirschsprung’s disease. Grossly, colon shows three zones- Constricted aganglionic zone, transition zone and dilated zone of ganglionosis. A transition zone, characterized by altered density and non uniform distribution of enteric neurons, lies between the aganglionic bowel and the proximal normal bowel.1, 2

Puri and Gosemann divided allied disorders of Hirschsprung’s disease into four: intestinal neuronal dysplasia (IND); isolated hypoganglionosis (HG); internal anal sphincter achalasia (IASA); and megacystic microcolon intestinal hypoperistalsis syndrome (MMIHS) in 2012.3

The diagnosis and extent of resection for the management of HD depend on the sensitive and specific identification of ganglion cells. This is often associated with hypertrophied (40um) nerve bundle. However, documenting aganglionosis is often difficult and tedious on routine hematoxylin-eosin (H&E) stained sections requiring multiple sections and there is the possibility of sampling tissue from the physiological ganglionic zone Therefore, different staining methods were developed to improve HD diagnostic accuracy. Acetylcholinesterase histochemical staining is the most commonly applied ancillary method and was reported to have excellent sensitivity and specificity for the diagnosis of HD.4 However, this method requires frozen specimen. Also it needs a quantitative and qualitative assessment, which difficult to perform on rectal suction biopsy. For this reasons, acetylcholinesterase staining is not feasible all the time. Several other immunohistochemical markers such as S-100, neuron specific enolase(NSE), C-Kit, PGP 9.5, and synaptophysin have been tested to identify ganglion cells in formalin-fixed, paraffin-embedded tissue specimens, but none has been demonstrated to be superior to acetylcholinesterase.

Recently, calretinin and microtubule-associated protein-2(MAP-2) were introduced as new markers that can be used to diagnose HD. MAP-2 is a cytoplasmic microtubule-stabilizing protein that it is a marker of neuronal differentiation.5, 6 Calretinin is a vitamin D-dependent calcium binding protein thought to involve in calcium signalling in the central nervous system.7 Since the first report of loss of expression of calretinin in the aganglionic bowel by Barshacket al. in 2004, only a handful of studies have investigated the utility of calretinin immunohistochemistry in the diagnosis. Calretinin positively stained the ganglion cells accompanied by a fibrillary pattern staining in the submucosal plexus of ganglionic bowel. Calretinin typically demonstrated cytoplasmic and nuclear positive reaction in contrast to only a cytoplasmic immune reactivity of MAP-2. In general, immunostaining for calretinin showed a more intense reactivity of HD. Now, choline transport (ChT) came out as new positive IHC marker avoiding use of frozen section.

Materials and Methods

Nature of study

Hospital based observational, cross sectional, prospective study.

Sample size

43 patients with signs and symptoms suggestive of Hirschsprung’s Disease and allied disorders attending tertiary health care. IHC is done on 86 rectal and colonic biopsies of these 43 patients. Surgical resected specimen is used as gold standard for hirschsprung’s disease and allied disorders (number of patients=27) cases while follow up is used as gold standard in non Hirschsprung’s disease cases(number of patients = 16).

Method

  1. Detailed history of the patient suspected of having Hirschsprung’s Disease and allied disorders will be taken.

  2. Investigations like X ray and ultrasonography of abdomen conducted.

  3. Intestinal biopsy is included of patients suspected of having Hirschsprung’s Disease and allied disorders.

  4. Slides prepared from paraffin embedded blocks studied for their histopathological and morphological features. At least 4 to 5 serial sections through block is taken for H&E stain.

  5. IHC performed on them using calretinin on paraffin block

Diagnostic criteria

Diagnostic criteria for non Hirschsprung’s disease in a rectal and colonic mucosal biopsy

  1. At least one ganglion cell is identified in one or more tissue sections and/or

  2. The calretinin immunostain shows distinct linear granular black fibres in the muscularis mucosa and lamina propria, extending upwards to a variable distance in between the crypts (positive staining) and stains ganglion cells (both nuclear and cytoplasmic) and nerve bundle in the submucosa if included in the biopsy.

Diagnostic criteria for Hirschsprung’s disease in a rectal mucosal biopsy

  1. Absent ganglion cells with or without presence of hypertrophic nerve bundles in the submucosa.

  2. With calretinin IHC, the biopsy demonstrates neither ganglion cells nor any stainable nerve fibres in mucosa as well as in sub mucosa. Negative staining of hypertrophied nerve bundle.

Diagnostic criteria for Isolated Hypoganglionosis

The number of ganglia in the myenteric plexus per millimeter colon is less than 1.52 according to the criteria introduced by Li and Zhu.

Diagnostic performances (e.g. sensitivity, specificity, positive and negative predictive values, and accuracy) of standard method which is done on H&E serial sections and calretinin IHC.

Biopsy selection and method:

Out of 86 biopsies, 69 were full thickness biopsies (include mucosa, submucosa and muscle layer) and 17 were partial thickness biopsies (include mucosa and submucosa only). Biopsies are taken at least 2 cm above pectinate line. (table1)

Table 1

Site of biopsy collection

Biopsy site No. of biopsies (n=86) Percentage
Rectum 47 54.65%
Sigmoid colon 11 12.8%
Descending colon 08 9.30%
Transverse colon 08 9.30%
Ascending colon 04 4.65%
Transition zone 03 3.48%
Colostomy 05 5.81%
Ileum 01 1.16%
Total Biopsies 86 100%

Result

Age wise distribution

Out of 43 patients 16 (37.22%) were in age group of 0-1 months. 14 patients (32.55%) were in age group of 1 month to 1 year while 13 (30.23%) patients were more than 1 year old.

Sex distribution

32 out of 43 (74.42%) patients were male while 11 (25.58%) patients were female with male to female ratio is 2.91:1.

Clinical presentation

Most of the patients clinically present with distension of abdomen, constipation, vomiting with unable to pass meconium.

Interpretation of IHC

  1. All 86 biopsies of 43 suspected patients were evaluated with both standard H and E stain and Calretinin IHC. Positive control shows no discrepancy.

  2. The concordance of calretinin result with gold standard (Surgically resected specimen for Hirschsprung’s disease and allied disorders while follow up routine for non HD diseases) was excellent with 100% agreement. Nerve staining with calretinin was peculiar with their granular, non-homogenous staining pattern and with very fine structure, focally forming a fine fibrillary network in lamina propria. Ganglion cells were also strongly stained.

  3. Out of 86 biopsies, 50 were calretinin negative suggestive of aganglionic segment (Table 2 ).

  4. 28 biopsies show positivity to nerve bundles as well as ganglion cell and 8 biopsies show positivity to nerve fibres only due to absence of ganglion cell in the given cut section.

  5. Only use of H and E stain gave false positive result with 13 biopsies out of 86 which were interpreted as absence of ganglion cell with or without hypertrophied nerve bundle.

  6. Only use of H and E stain lead to misdiagnosis as Hirschsprung’s Disease in 9 out of 43 cases (Table 3).

  7. 1 hypogangliosis case show absence of ganglion cell in H and E stain, while calretinin intensely stained single ganglion.

  8. H and E stain showed 72.0% specificity with 78.12% positive predictive value and 86.00% accuracy. Calretinin showed 100% sensitivity, specificity, positive & negative predictive value and accuracy (Table 4).

Table 2

Classification of cases (Total =43)

Stains Hirschsprung’s disease Isolated hypogangliosis Non Hirschsprung’s disease
Calretinin 26 01 16
H&E 35 00 08

Table 3

Discrepant result between Calretinin and H and E stain (Total biopsy 86)

H and E staining (Bx=86) Calretinin(Bx=86)
Ganglion present 22 36
Ganglion absent with or without hypertrophied nerve bundle. 64 50

Table 4

Predictive values and sensitivity/specificity of immunohistochemical evaluation

Indicators Definition H and E stain Calretinin
Number of biopsy 86 86
Sensitivity TP/(TP+FN) 50/(50+0) ;100% 50/(50+0); 100%
Specificity TN/(TN+FP) 36/(36+14); 72.0% 36/(36+0); 100%
Positive predictive value TP/(TP+FP) 50/(50+14); 78.12% 50/(50+0)100%
Negative predictive value TN/(TN+FN) 36/(36+0); 100% 36/(36+0);100%
Accuracy (TP+TN)/TP+TN+FP+FN (50+36)/100; 86.00% (50+36)/86; 100%
Abbreviations: TP: True positive, TN: True negative, FP: False positive, FN: False negative

Table 5

Formalin fixed rectal and intestinal biopsies (n/total=86)

Full Thickness biopsy (n=69) Rectal suction/partial thickness biopsy (n=17 biopsies)
Ganglionic segment (n=29) Aganglionicsegment (n=40) Ganglionic segment (n=7) Aganglionicsegment (n=10)
H and E stain 19 50 03 14
Calretinin 29 40 07 10

Statistical analysis

McNemar chi-squared statistic with Yates correction of 0.5 is 8.02778 with corresponding p- value is 0.00026 (p value <0.05), consider as significant result, rejecting null hypothesis.Hence, diefference between H and E stain and calretinin is statisticaly significant.

Types of Hirschsprung’s disease

Out of 26 cases of Hirschsprung’s disease, 20 were of short segment type (maximum upto sigmoid colon aganglionosis), 4 were of long segment type (upto splenic flexure, 01 of total colonic agnaglionosis (involve all of large intestine) and 01 of skip segment type.

Partial thickness biopsy/ Rectal suction biopsy

Out of 86 biopsies, 69 were full thickness biopsies include mucosa, submucosa and muscle layer. 17 were rectal suction biopsy include mucosa and submucosa only (Table 5).

H and E stain showed 63.63% specificity with 71.42% positive predictive value and 80.95% accuracy in partial thickness biopsy, while calretinin showed 100% sensitivity, specificity, positive & negative predictive value and accuracy.

Transition zone

3 biopsies were taken from clinically and radiologically known transition zone. Out of 3 biopsies, 2 were calretinin negative and 1 was positive for ganglion as well as nerve fibre. Only use of H and E stain lead to false positive result for aganglionic zone with 1 out of 3 biopsies.

Figure 1

a: H and E stain, 100x: shows nerve bundles along with ganglions in muscle layer; b: Calretinin stain gives positive staining of nerve bundles as well as ganglions, suggestive of ganglionic segment

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/9678e689-d927-4790-8846-05a27dd13295/image/670ecf7a-2268-4243-80c7-168bd07b8564-uimage.png

Figure 2

a: H and E stain 400x, shows ? ganglion cell; b: calretinin stain showed intense positive staining of cytoplasm and nuclei of ganglion cell, which confirm ganglionic segment

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/9678e689-d927-4790-8846-05a27dd13295/image/95c652a6-8b84-45f9-af53-cbedbff8aaef-uimage.png

Figure 3

a: H&E (400x); Hypertrophied nerve bundle; b: Calretinin (400x); -ve staining of nerve bundle; Aganglionic segment

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/9678e689-d927-4790-8846-05a27dd13295/image/d80a7c7b-7024-4103-9416-1ac06da9e879-uimage.png

Discussion

Histopathologic analysis remains the mainstay for diagnosis of HD. Hirschsprung’s disease has a complex pathogen­esis that, to date, is not completely understood. Significant progress has been done for a better molecular characterization; there is a very strong body of literature pointing to specific genes being involved in the developments and migration of the enteric nervous system. For example mutations in RET on chromosome 10q11.2 was shown to be responsible of approximately 40% of the sporadic cases of HD.8, 9, 10

In 1994 McConalgueet al. demonstrated that the calretinin antibody highlights different neuronal populations in the large intestine. Since then a number of comparative studies have been published on the expression of calretinin in Hirschsprung’s disease and its utility as a marker for assisting in the diagnosis of HD. Calretinin, a 29 kD calcium binding protein is expressed primarily in neurons of central and peripheral nervous system and as a rich network in the ENS. The functional interpretation of calretinin immunohistochemistry in HD might be the subject of further studies, but the Ca++- deficient status of the aganglionic bowel might be related to deficient Ca++ receptor expression, which was shown by Piotrowska et al. in their study.11 This protein is involved in the transport of calcium, and when stained, is seen as thin fibrillary network in the mucosa as an indirect evidence of ganglionosis.

Most common age group was 1 day to 8 years. Age group of our study is very much comparable with all 7 other studies to which it is compared like Young et al,12 Anbardar et al,13 Kannaiyan et al14 and Zuikova et al.15 Kannaiyan et al. and zuikova et al has very wide range of age group with mean is slightly at older age. Volpe et al has a mean age in infant age group. Our study has mean age in 2nd year of life as of Yadav et al, Kacar et al,16 Guinard- Samuel et al17 and Rakshani et al.18 Number of the patients were almost equally distributed in neonates, infants and >1 year of age. Young et al have most of the patients in neonates (45.4%) with 36% of patients in infant age group. While Zuikova et al has maximum number of patients in >1 year age group (54.2%). Kannaiyan et al and Anbardar et al has maximum patients in 0-1 month age group 63% and 77% respectively.

All studies show predominance of this disease in male. Our study has Male: Female ratio of 2.91:1. Male to female ratio of Kacar et al is maximum i.e 4:1, while young et al has 2.14:1, kannaiyan et al 3.28:1, Rakshani et al 2.03:1.

Cause of male predominance is still unknown but many believes genetic association to this factor.

Along with our study; Yadav, Kacar and Musa et al19 showed all predictive values 100% with calretinin, which is excellent result. Zuikova et al shows sensitivity of 90.5% and accuracy of 91.4%, which is less than other studies but still its much higher.

Ambardar et al showed sensitivity of 96.7% and negative predictive value of 98%, but specificity and positive predictive value of 100%. It’s overall accuracy is 98%.

Conclusion

Though there has been recent advances in molecular as well as radiological diagnosis histopathology is mainstay for diagnosis of Hirschsprung’s disease. Rare disease yet one of the common cause for neonatal constipation is grave if unidentified and untreated. H&E diagnosis require serial cut sections as density of ganglion cell in terminal rectum is low. This lead to failure of adequate sampling.

Pattern of calretinin is very simple; its either positive or negative. It does not require fresh and frozen tissue, accurate result even with rectal suction biopsy, It stains well in immature ganglions, stains satisfactorily even on low level biopsies and it is great help to identify transition zone. Calretinin as adjuvant with H&E stain, significantly reduces interpretation error and improves diagnosis to 100%. It is of great help to identify transition zone which is necessary for management. It stains well in low level rectal biopsy and immature ganglion. Calretinin improved diagnosis to excellent 100% even in rectal suction biopsy and hence improves management

Large scale studies are requiring for better predictability of the diagnosis and future management and rehabilitation of Hirschsprung’s disease patient. Calretinin IHC should always be used in addition to limited H&E section because of the heterogeneous nature of the disease.

Take Home Massage

  1. Calretinin gives negative staining to nerve fibres in mucosa, lamina propria as wells as muscularis muscle in HD cases. Hence even if ganglion is absent in given section, negative staining of these fibres will give diagnosis of HD.

  2. Calretinin improved diagnosis to excellent 100% even in rectal suction biopsy and hence improves management.

  3. No need of multiple level biopsy for calretinin IHC. Hence significantly reduce tedious time consuming search for ganglion cell on hundreds of section in H and E stain slides.

Source of Funding

None.

Conflict of Interest

None.

References

1 

Sylvain Kleinhaus Scott J. Boley Michael Sheran William K. Sieber Hirschsprung's disease a survey of the members of the Surgical Section of the American Academy of PediatricsJ Pediatr Surg1979145588970022-3468Elsevier BV

2 

Sachiyo Suita Tomoaki Taguchi Satoshi Ieiri Takanori Nakatsuji Hirschsprung's disease in Japan: analysis of 3852 patients based on a nationwide survey in 30 yearsJ Pediatr Surg20054011972020022-3468Elsevier BV

3 

P Puri J H Gosemann Variants of Hirschsprung’s diseaseSemin Pediatr Surg20122143108

4 

M M Santos U Tannuri M C Coelho Study of acetylcholinesterase activity in rectal suction biopsy for diagnosis of intestinal dysganglionoses: 17-year experience of a single centerPediatr Surg Int20082467159

5 

A Caceres LI Binder MR Payne P Bender L Rebhun O Steward Differential subcellular localization of tubulin and the microtubule- associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodiesJ Neurosci1984423944100270-6474, 1529-2401Society for Neuroscience

6 

Jacques Nunez Itzhak Fischer Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regenerationJ Mol Neurosci199783207220895-8696, 1559-1166Springer Science and Business Media LLC

7 

K.G. Baimbridge M.R. Celio J.H. Rogers Calcium-binding proteins in the nervous systemTrends Neurosci199215830380166-2236Elsevier BV

8 

M Hiradfar N Sharifi M Khajedaluee N Zabo¬linejad J S Taraz Calretinin immunohisto¬chemistry: and aid in the diagnosis of Hirschsprung’s diseaseIran J Basic Med Sci201215510539

9 

Ayper KACAR Ata Turker ARIKOK Mujdem Nur AZILI Gunay EKBERLI AGIRBAS Tugrul TIRYAKI Calretinin immunohistochemistry in Hirschsprung’s disease: An adjunct to formalin-based diagnosisTurk J Gastroenterol2012233226331300-4948, 2148-5607AVES Publishing Co.

10 

Susan K. Holland Preetha Ramalingam Robert H. Podolsky Michelle D. Reid-Nicholson Jeffrey R. Lee Calretinin immunostaining as an adjunct in the diagnosis of Hirschsprung diseaseAnn Diagn Pathol201115532381092-9134Elsevier BV

11 

Anna Piaseczna Piotrowska Valeria Solari Prem Puri Distribution of Ca2+-Activated k+ channels, SK2 and SK3, in the normal and Hirschsprung’s disease bowelJ Pediatr Surg2003386978830022-3468Elsevier BV

12 

Lokendra Yadav Usha Kini Kanishka Das Suravi Mohanty Divya Puttegowda Calretinin immunohistochemistry versus improvised rapid Acetylcholinesterase histochemistry in the evaluation of colorectal biopsies for Hirschsprung diseaseIndian J Pathol Microbiol2014573369750377-4929Medknow

13 

Mohammad Hossein Anbardar Bita Geramizadeh Hamid Reza Foroutan Evaluation of Calretinin as a New Marker in the Diagnosis of Hirschsprung DiseaseIran J Pediatr20152522008-2142, 2008-215010.5812/ijp.367Kowsar Medical Institute

14 

L Kannaiyan S Madabhushi R Malleboyina N K Are K R Reddy B Rao Calretinin immunohistochemistry: A new cost-effective and easy method for diagnosis of Hirschsprung's diseaseJ Indian Assoc Pediatr Surg2013182668

15 

Valerija Zuikova Ivanda Franckevica Ilze Strumfa Ivars Melderis Ilze Strumfa, Ivars Melderis. Immunohistochemical Diagnosis of Hirschsprung’s Disease and Allied DisordersActa Chirurgica Latviensis 201515110.1515/chilat-2016-0010

16 

Ayper KACAR Ata Turker ARIKOK Mujdem Nur AZILI Gunay EKBERLI AGIRBAS Tugrul TIRYAKI Calretinin immunohistochemistry in Hirschsprung’s disease: An adjunct to formalin-based diagnosisTurk J Gastroenterol2012233226331300-4948, 2148-5607AVES Publishing Co.

17 

Vincent Guinard-Samuel Arnaud Bonnard Pascal De Lagausie Pascale Philippe-Chomette Corine Alberti Alaa El Ghoneimi Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung diseaseMod Pathol200922101379840893-3952, 1530-0285Springer Science and Business Media LLC

18 

Nasser Rakhshani Mohammadreza Araste Farhad Zamani Mahshid Panahi Fahimeh Safarnezhad Tameshkel Masoud Reza Sohrabi Hirscshprung’s disease diagnosis: Calretinin marker role in determining the presence or absence of ganglion cellsIran J Pathol201611440915

19 

Zaidoon A Musa Ban J Qasim Haider F. Ghazi Wahab A. K. Al Shaikhly Diagnostic roles of calretinin in hirschsprung disease: A comparison to neuron-specific enolaseSaudi J Gastroenterol20172316061319-3767Medknow



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijpo.2020.081


Article Metrics






Article Access statistics

Viewed: 2181

PDF Downloaded: 872